Sub title


Description will be displayed here.

Our Partners

Global Partnerships

Companies, we together create the future

Abrax has reformulated and optimized MC903 (calcipotriene) and is aiming for approval by the US FDA in the shortest possible time. Although a Japanese bio-venture, Abrax is unique in that it has drawn a roadmap in its global market strategy together with its global partners.

Our Science

Our Innovative Science

Creating a Healthy and Happy Future

Since its establishment, Abrax Japan has been a bio-venture company that aims to turn discoveries made through research led by Dr. Taku Kambayashi into reality for the promotion of health.

Our Technology

Our Approach to Healthy Life

Our Technology Challenged by Innovative Deployments

Description will be displayed here.